SCAI

Sorry! To unlock all site features, we'll need to collect some information from you.
Unit 8.5b: Stent Thrombosis: Incidence, Timing, Outcome, Optimizing Pharmacology
Martin B. Leon, MD — Columbia University Medical Center, Cardiovascular Research Foundation

Duration:1 hour

Faculty Disclosure

Nothing to Disclose

Learning Objectives

Describe sirolimus-eluting stent (SES) components and drug actions
Explain the angiographic and clinical results of randomized trials comparing SES and bare metal stents (BMS)
Review the effects of SES in complex lesion subsets
Discuss the frequency of early and late stent thrombosis after SES implantation

* Message:

Unit 8.5b: Stent Thrombosis: Incidence, Timing, Outcome, Optimizing Pharmacology